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Abstract. 
 
Duchenne muscular dystrophy is a lethal re-
cessive disease characterized by widespread muscle
damage throughout the body. This increases the difﬁ-
culty of cell or gene therapy based on direct injections
into muscles. One way to circumvent this obstacle
would be to use circulating cells capable of homing to
the sites of lesions. Here, we showed that stem cell anti-
gen 1 (Sca-1), CD34 double-positive cells puriﬁed from
the muscle tissues of newborn mice are multipotent in
vitro and can undergo both myogenic and multimyeloid
differentiation. These muscle-derived stem cells were
isolated from newborn mice expressing the LacZ gene
under the control of the muscle-speciﬁc desmin or
troponin I promoter and injected into arterial circula-
tion of the hindlimb of 
 
mdx
 
 mice. The ability of these
cells to interact and ﬁrmly adhere to endothelium in
 
mdx 
 
muscles microcirculation was demonstrated by in-
travital microscopy after an intraarterial injection. Do-
nor Sca-1, CD34 muscle-derived stem cells were able to
migrate from the circulation into host muscle tissues.
Histochemical analysis showed colocalization of LacZ
and dystrophin expression in all muscles of the injected
hindlimb in all of ﬁve out of ﬁve 8-wk-old treated 
 
mdx
 
mice. Their participation in the formation of muscle ﬁ-
bers was signiﬁcantly increased by muscle damage done
48 h after their intraarterial injection, as indicated by
the presence of 12% 
 
b
 
-galactosidase–positive ﬁbers in
muscle cross sections. Normal dystrophin transcripts
detected enzymes in the muscles of the hind limb in-
jected intraarterially by the mdx reverse transcription
polymerase chain reaction method, which differentiates
between normal and mdx message. Our results showed
that the muscle-derived stem cells ﬁrst attach to the
capillaries of the muscles and then participate in regen-
eration after muscle damage.
Key words: hemopoietic • dystrophin • gene therapy
• muscle-derived cell • transplantation
 
Introduction
 
Duchenne muscular dystrophy (DMD)
 
1
 
 is an inherited
muscle disease characterized by the absence of dystrophin
in the membrane-associated cytoskeleton of muscle fibers
(Hoffman et al., 1987; Emery, 1989) resulting in a lethal
muscle wasting disease. No cure is currently available for
DMD. An experimental model of DMD is the mdx/mdx
mouse where the absence of the membrane-associated
dystrophin is caused by a point mutation (Sicinski et al.,
1989). Using this model, different experimental therapies
have been investigated, including transplantation of myo-
blasts from normal donor mice (Partridge et al., 1989).
Transplanted mononuclear muscle precursor cells were
shown to fuse with mature muscle myofibers of the dystro-
phic host to produce a hybrid fiber expressing dystrophin.
Despite the good efficacy of dystrophin gene transfer ob-
tained in the mdx mouse model, myoblast transplantation
in DMD patients has been disappointing (Tremblay et al.,
1993; Mendell et al., 1995). Very few myoblasts survived in
the host muscles after transplantation and only a small
proportion of the surviving cells could express dystrophin
or its mRNA (Gussoni et al., 1997). This might have been
due to inadequate immunosuppression, or to the advanced
state of the disease, which results in extensive muscle fi-
 
brosis and adipose substitution. The newly introduced myo-
 
blasts did not migrate to damaged areas, but remained
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 BCECF, 29,79-bis-(carboxyethyl)-
5(and-6) carboxy-fluorescein; DMD, Duchenne muscular dystrophy; gal,
galactosidase; IL, interleukin; MHC, myosin heavy chain; PECAM, plate-
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relatively close to the site of injection. The large number
of myoblasts required to treat all of the affected muscles as
well as the inability of the transplanted cells to migrate
from the injection site increase the difficulty of using this
method to treat DMD (Tremblay et al., 1993; Mendell et
al., 1995).
Considerable interest currently surrounds a population
of multipotential muscle stem cells that could be trans-
planted into dystrophic 
 
mdx
 
 and human skeletal muscle
and repopulate the diseased tissue. Interestingly, bone
marrow transplantation in myeloablated mice resulted not
only in myeloid reconstitution, but also in some trans-
planted cells participating in myogenesis, suggesting that a
population of transplanted bone marrow–derived stem
cells had myogenic potential (Ferrari et al., 1998). As such,
bone marrow transplantation has been performed to cor-
rect dystrophin deficiency in the 
 
mdx
 
 mouse, though only
a few fibers turned dystrophin positive after transplanta-
tion (Gussoni et al., 1999). After bone marrow transplan-
tation, donor-derived cells have also been found in multi-
ple nonhemopoietic tissues, including liver (Petersen et al.,
1999), vascular endothelial cells (Shi et al., 1998), astroglia
in the brain (Eglitis and Mezey, 1997), and bone (Horwitz
et al., 1999). Although bone marrow contains many cell
types that could account for this migration in many tissues,
it is possible that mesenchymal stem cells are directly or
indirectly involved.
In early ontogeny, hemopoiesis is tightly associated with
the endothelial network; this is particularly apparent in
two spatially and chronologically distinct sites: the ex-
traembryonic blood islands and the dorsal aorta (Parda-
naud et al., 1996; Dzierzak et al., 1997). These aspects
suggest developmental relationships between these two
lineages, i.e., they might derive from a common bipotent
endothelial–hematopoietic precursor (hemangioblastic)
(Sabin, 1917; Murray, 1932; Wagner, 1981).
CD34 is a sialylated transmembrane glycoprotein that is
present in vascular endothelium and myeloid progenitors
cells (Berenson et al., 1988; Fina et al., 1990). In mice, stem
cell antigen-1 (Sca-1), which belongs to the Ly-6 gene fam-
ily, is a marker of hematopoietic stem cells (van de Rijn et
al., 1989). Both of these cell surface markers have been
shown to be present on a population of multipotent stem
cells in a murine skeletal muscle (Jackson et al., 1996; Pit-
tenger et al., 1999).
In this study, we used a muscle culture system for
facilitating the enrichment and purification of Sca-1
 
1
 
and CD34
 
1
 
 cells. This population was characterized by
FACS
 
®
 
. These cultured muscle-derived stem cells possess
a great proliferative potential resulting in a large expan-
sion of colony-forming cells with myogenic potential.
We used Sca-1
 
1
 
CD34
 
1
 
 enriched muscle-derived cells
isolated from normal mouse newborns to evaluate
whether these cells are able to migrate from the blood-
stream to the muscles after intraarterial injection and pro-
liferate and participate in myogenesis when injected in
 
mdx 
 
mice. Using the intravital microscopy, we showed
that these cells adhere firmly to the lining of mdx muscle
microvessels. Transgenic newborn mice carrying a re-
porter LacZ gene were also used to follow the long term
fate of injected cells. The LacZ gene was under the control
of regulatory elements of desmin or troponin I gene which
 
are expressed in skeletal muscle and heart (Halluaer et al.,
1993; Li et al., 1997). Mice were analyzed for the presence
of 
 
b
 
-galactosidase (
 
b
 
-gal)–positive cells and dystrophin-
positive fibers to trace the distribution of cells in the tis-
sues.
 
Materials and Methods
 
This work was authorized and supervised by the Canadian University An-
imal Care Committee and was conducted according to the guidelines set
by the Canadian Council of Animal Care.
 
Transgenic Mice
 
Muscle-derived cells were established from two strains of transgenic mice.
One strain was the TnILacZ 1/29 bred with a CD1 background (gift from
Dr. K. Hasting, McGill University, Montreal, Canada). These transgenic
mice express the 
 
b
 
-gal gene under the control of the promoter of the quail
fast skeletal muscle troponin I gene (Halluaer et al., 1993).
The second strain was the Des-LacZ bred onto the C57BL/10J back-
ground (gift from Dr. D. Paulin, Paris University, France). These trans-
genic mice specifically express the reporter gene LacZ in skeletal muscle
(des-nlsLacZ) as described previously (Li et al., 1997). In these mice, the
 
Escherichia coli
 
 LacZ gene carrying a nuclear localizing signal was in-
serted in-frame into the first exon of the desmin gene. Founder animals
were identified by PCR analysis of tail DNA using primers specific for the
desmin-lacZ transgene. Primer sequences were as follows: Des1 and
LacZ430R (sense), 5
 
9
 
-TTGGGGTCGCTGCGGTCTAGCC-3
 
9
 
; Des1R
(antisense), 5
 
9
 
-GGTCGTCTATCAGGTTGTCACG-3
 
9
 
; LacZ430R (anti-
sense),
 
 
 
5
 
9
 
-GATCGATCTCGCCATACAGCGC-3
 
9
 
.
 
 
 
These primers yield a
product of 
 
z
 
450 bp for the LacZ transgene and a supplementary 350-bp
band for the desmin gene. Homozygous male transgenic mice were bred
by backcrossing with C57BL/10J females. Thus, all experiments were per-
formed with hemizygous embryos which expressed the LacZ transgene.
 
Isolation of Muscle-derived Cells by Preplatings
 
Muscle-derived cells were isolated using a protocol described previously
(Rando and Blau, 1994). The forelimbs and hindlimbs were removed from
neonatal desLacZ and TnILacZ mice and the bone was dissected. The re-
maining muscle mass was minced into a coarse slurry using razor blades.
Cells were enzymatically dissociated by adding 0.2% collagenase type XI
and 0.1% trypsin for 1 h at 37
 
8
 
C. The muscle cell extract was preplated on
the culture flasks using a slight modification of the technique described by
Qu et al. (1998), i.e., the flasks were not gelatin coated and a different cul-
ture medium was used (see below). Different populations of muscle-
derived cells were isolated based on the number of preplates performed
on the culture flasks. Preplate 1 (pp1) represented a population of muscle-
derived cells that adhered in the 1 h after isolation, pp2 in the next 2 h, and
the subsequent preplates were obtained at 24-h intervals (pps 3–6). The
proliferation medium was F10-Ham supplemented with 20 
 
m
 
g/ml pancre-
atic insulin, 50 ng/ml stem cell factor (SCF), 15% FBS, and 1% penicillin/
streptomycin. All the culture medium supplies were purchased from
GIBCO BRL.
 
Characterization of Muscle-derived Cells for
FACS
 
®
 
 Analysis
 
FITC-conjugated RAM34 (anti-CD34; rat IgG2a) and phycoerythrin-con-
jugated D7 (anti–Ly-6A/E [anti–Sca-1]; rat IgG2a) were purchased from
BD PharMingen. Some antibodies were also received as hybridomas. Hy-
bridomas M1/70.15.11.5 (anti–Mac-1; rat IgG2b), GK1.5 (anti-CD4, rat
IgG2b), and 53-6.72 (anti-CD8; rat IgG2a) were purchased from Ameri-
can Type Culture Collection. For antibody staining, cells were suspended
in HBSS containing 2% FCS and 1 mM Hepes at 10
 
6
 
 cells per ml. The an-
tibodies were added at 1:50 to 1:100 dilutions. The lineage cocktail used
was comprised of the following: CD4, CD8, and Mac-1. The mixture was
incubated on ice for 10 min and resuspended in media containing goat
anti–rat antibody conjugated to phycoerythrin and incubated for 10 min
on ice. After washing, the cells were resuspended in 1:3 volume rat serum
(Cappel Laboratories) and 2:3 HBSS. The method for the reaction of cell
suspensions with Sca-1 and CD34 antibodies for flow cytometry has been
described previously (Forni, 1979; Lange et al., 1999; Nakamura et al.,
1999). Stained cells were then passed through a 70-
 
m
 
m nylon filter (Falcon 
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Plastics) and subjected to a two-color flow cytometric analysis. Gating on
the lymphoid region was used to exclude dead cells by size and granular-
ity. Flow cytometric analysis was performed on a FACScan™ flow cytom-
eter using CELLQuest™ software (Becton Dickinson) with 10,000 events
recorded for each sample.
 
In Vitro Self-Renewal and Pluripotentiality of
Muscle-derived Cells
 
The ability of muscle-derived cells to undergo differentiation into hemato-
poietic lineages was tested with methylcellulose culture using a method
described previously (Delassus and Cumano, 1996). In our experiments, 1
ml of culture medium contained an appropriate number of fresh preplat-
ing cells (
 
z
 
10
 
5
 
), 1.2% methylcellulose (Fisher Scientific), IMDM contain-
ing 15% FBS, 1% deionized BSA (Sigma-Aldrich), 0.1 mmol/liter 2-mer-
captoethanol (Eastman Kodak Co.), 150 ng/ml recombinant mouse SCF
(Sigma-Aldrich), and 10% (vol/vol) X63 interleukin (IL)-3–conditioned
medium. The mixture was incubated in 35-mm nontissue culture dishes
(Falcon Labware) under humidified 5% CO
 
2
 
 atmosphere at 37
 
8
 
C. The
number of colonies was scored after 8 d of culture using an inverted mi-
croscope. Colony types were confirmed by lifting them from the semisolid
medium on day 8 of culture, and cytospin preparations were stained with
May-Grunwald-Giemsa. To determine the myogenic ability, muscle-
derived cells were maintained in proliferation medium as they reached
60–70% confluence. At this time, cells were exposed to differentiation me-
dium consisting of Ham’s F10 supplemented with 5% FBS and antibiotics
as described above. After 14 d of cultures, enumeration of differentiated
myoblasts containing two or more nuclei (i.e., fusion index) was assessed in
all preplates under mitotic or differentiation medium. Differentiated myo-
blasts were detected by immunostaining with antibody reactive to slow
myosin heavy chains (MHCs), desmin, and dystrophin. To determine
whether pp6 cells exhibit stem cell characteristics of self-renewal, individ-
ual clones were analyzed. To establish clones, pp6 were plated at 
 
z
 
10 cells/
cm
 
2
 
, grown to 50–150 cells per colony, isolated with cloning cylinders, and
transferred to separate wells and finally to individual flasks.
 
In Vitro Immunohistochemistry of Muscle-derived Cells
 
For immunocytochemistry, cells were plated in a Lab-tek chamber slide
(Life Technologies) until confluence, fixed in ethanol 70% in PBS for 1
min, and permeabilized for 5 min with 0.5% Triton X-100 in PBS. Cells
were than incubated with primary antibodies: M-cadherin (1:50), platelet
endothelial cell adhesion molecule (PECAM; 1:100; Santa Cruz Biotech-
nology, Inc.), Mac-1 (1:50; Santa Cruz Biotechnology, Inc.); and anti-
desmin monoclonal antibodies (1:100; Sigma-Aldrich) overnight at 4
 
8
 
C.
After washing with PBS, cells were incubated with FITC-conjugated goat
anti–mouse IgG for 1 h at room temperature and examined by epifluores-
cence microscopy. A slow MHC antibody (Ylem) was visualized using an
HRP-coupled secondary antibody (Bio-Rad Laboratories) in PBS con-
taining 0.6 mg/ml diaminobenzidine (Sigma-Aldrich).
 
Dystrophin and Myosin Western Blotting
 
To determine the in vitro myogenic ability of the muscle-derived cells,
proteins were extracted as described previously (Anderson and Davison,
1999) from cells obtained from all preplatings (pp0–pp6) after culture in a
differentiation medium for 14 d. The concentration of proteins was deter-
mined using the Lowry technique. 100 
 
m
 
g of extracted proteins was sepa-
rated on 6% polyacrylamide gels and electrotransferred onto nitrocellu-
lose membranes (Bio-Rad Laboratories). To ensure that equivalent
amounts of proteins were loaded for each sample, the membrane was
stained with Ponceau S. (Sigma-Aldrich). Membranes were subsequently
incubated with a monoclonal antibody directed against dystrophin (NCL-
DYS 2; Novocastra) and MHCs and revealed using a commercially avail-
able chemiluminescence kit (Ultra ECL; Pierce Chemical Co.). Mem-
branes were then exposed to BioMax autoradiographic films (Eastman
Kodak Co.), which were developed and scanned with a densitometer.
 
Intravital Microscopy
 
Animals were anesthetized with an intraperitoneal injection of physio-
logic saline containing ketamine (5 mg/ml) and xylazine (1 mg/ml). The
right common carotid artery was cannulated for the injection of fluores-
cent cells toward the aortic arch, then the skin covering the pectoral mus-
cle was reflected and a coverslip (24 
 
3
 
 24 mm) was applied and fixed with
silicon grease. A round camera with 11-mm internal diameter was at-
 
tached on the coverslip and filled with water. An intravital microscope
(BX50WI; Olympus) equipped with water immersion objectives (Achro-
plan, focal distance 3.3 mm, NA 0.5
 
`
 
; Olympus) was used for these exper-
iments. 148 kD of FITC-dextran (Sigma-Aldrich) was injected to evaluate
the microvascular dimensions. The muscle-derived cells were fluores-
cently labeled with 2
 
9
 
,7
 
9
 
-bis-(carboxyethyl)-5(and-6) carboxy-fluorescein
(BCECF; Molecular Probes). After staining for 30 min at 37
 
8
 
C (2 
 
m
 
g
BCECF/10
 
7
 
 cells), the cells were washed and resuspended at 10
 
7
 
 cells/ml
in RPMI 1640 (BioWhittaker) containing 10% FBS. 7 
 
3
 
 10
 
5
 
 of BCECF-
labeled cells were injected in the right carotid artery by a digital pump
(SP100; World Precision Instruments) at a flow rate of 1 
 
m
 
l/s. The recipi-
ent was maintained at 37
 
8
 
C by a stage-mounted strip heater Linkam
CO102 (Olympus). All scenes were recorded on videotape using a silicon-
intensified-target videocamera (VE 1000-SIT; Dage MTI), a time and
frame counter (ELCA), and a high picture quality SVHS VCR (Pana-
sonic). The recordings were digitalized on Casablanca digital system (MS
Macrosystem Computer GmbH).
 
Intraarterial Transplantation of Sca-1, CD34
Muscle-derived Cells into mdx
 
Approximately 5 
 
3 
 
10
 
5
 
 cells prepared from pp6 of newborn Des-LacZ
mice were injected into five 3-mo-old C57BL/10ScSn 
 
mdx/mdx
 
. Mice were
anesthetized with an intraperitoneal injection of physiologic saline (10 ml/
kg) containing ketamine (5 mg/ml) and xylazine (1 mg/ml) and a limited
low midline laparotomy was performed. The intestines were exposed and
cells were injected via a 0.20-mm-diameter needle inserted into the iliac
artery. The needle was connected to a peristaltic pump by a heparinated
Tygon tube (Ika Labortechnik). This Tygon tube was connected to a ster-
ile Eppendorf tube containing 5 
 
3 
 
10
 
5 
 
cells/50 
 
m
 
l. Cells were delivered by
laminar flow (5 
 
m
 
l/s) over a period of 10 s. The blood flow was not stopped
before or during this procedure. There was no visible damage to the vessel
wall during or after operation. The body wall muscle was closed with su-
tures and the skin with surgical staples. Intraarterial delivery of 5 
 
3 
 
10
 
5
 
cells of preplating six prepared from the newborn TnILacZ mice was also
performed in six CD1 mice. In these mice, mechanical muscle damage was
induced with three needle insertions in the tibialis anterior (TA) of the in-
jected hindlimb 48 h after the intraarterial injection. The mdx and CD1
mice were killed 21 d after injection. To evaluate the effect of muscle de-
generation–regeneration on the intraarterial injection of pp6, we tested
the effects of an intense swim on six mice. A group of three mdx mice was
also used to evaluate the fate of pp6 cells injected intraarterially 48 h after
an intense swim. For all the transplantations, the immunosuppressor
FK506 (Fujisawa Pharmaceutical Co., Ltd.) was administered intraperito-
nealy at 2.5 mg/kg beginning on the day of the injection and maintained
until the animals were killed.
 
Endothelial Cell Line
 
We used an immortalized endothelial cell line isolated from a transgenic an-
imal carrying a thermolabile SV40 T antigen and LacZ gene reporter under
the control of the human vimentin promoter (Vicart et al., 1994). To pro-
duce this cell line, enriched fractions of microvessels were obtained by gra-
dient centrifugation on a 15% BSA cushion of brain homogenates and pre-
incubated with 0.2% collagenase for 10 min at 37
 
8
 
C. Thereafter, the
microvessel-enriched fraction was treated with trypsin for 10 min at 37
 
8
 
C,
plated in gelatin-coated petri dishes, and grown in DME supplemented with
20% FBS. The endothelial cell line proliferated indefinitely under the per-
missive condition (i.e., 33
 
8
 
C) and underwent normal differentiation at 37
 
8
 
C.
 
Muscle-derived Cells and Endothelial Cell 
Transplantation Directly in the TA Muscle
 
To determine whether the origin of the muscle-derived cells influenced
their myogenic ability, intramuscular injections of pp6 and of endothelial
cell line were performed. In these experiments, 12 CD1 mice (The Jack-
son Laboratory), 
 
z
 
3 mo old, were injected with the pp6 (
 
n
 
 = 6) derived
from the TnILacZ mice or with the endothelial cell line (
 
n
 
 = 6). A car-
diotoxin (5 
 
m
 
g/
 
m
 
l) pretreatment was performed in the right TA muscle
48 h before cell transplantation. The mice were anesthetized as described
above. The skin was excised to expose the right TA muscle and 15 
 
m
 
l con-
taining 2
 
 3 
 
10
 
6
 
 cells was slowly injected with a glass micropipette with a
50-
 
m
 
m tip (Drummond Scientific Co.). The skin was then closed with fine
sutures and immunosuppression with FK506 was administered until the
animals were killed 30 d after the transplantation. 
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Detection of Dystrophin, 
 
b
 
-Actin, and desLacZ Genes
 
The brain, lungs, diaphragm, liver, kidneys, heart, bones with bone mar-
row, and muscles were taken from the mice injected intraarterially with
Sca-1, CD34 positive cells (i.e., pp6) and divided in two identical halves.
One half was used to isolate genomic DNA and total RNA, the other half
was cryostat-sectioned and used for X-gal histochemistry and immunode-
tection of dystrophin. Distribution of muscle-derived cells (i.e., pp6) in the
tissues of mdx mice was assessed by PCR for dystrophin and desLacZ
genes. Genomic DNA was isolated as described previously (Shrager et al.,
1992). To detect the normal (injected pp6) and mutant (mdx tissues) dys-
trophin genes, primers were located on exon 23 of the mouse dystrophin
gene which contains a point mutation in the 
 
mdx
 
 mouse (Sicinski et al.,
1989). The primer dystrophin forward was designed to introduce a new
site for the restriction enzyme MaeIII in the sequence of normal dystro-
phin cDNA, but not in the mutated cDNA of 
 
mdx 
 
mice (Asselin et al.,
1995; Torrente et al., 2000). An initial denaturation at 94
 
8
 
C for 5 min was
followed by 35 cycles of denaturation at 94
 
8
 
C for 30 s, annealing at 50
 
8
 
C
for 45 s, extension at 72
 
8
 
C for 30 s, and a final extension at 72
 
8
 
C for 10
min. The 200-bp PCR product was extracted with phenol/chloroform, pre-
cipitated with ethanol resuspended in 15 ml of H
 
2
 
O, and incubated with
MaeIII at 55
 
8
 
C for at least 5 h.
For reverse transcription (RT)-PCR, total RNA was extracted using
the RNAzol™ B isolation kit (Biotecx Laboratories, Inc.) and was re-
verse-transcribed for 1 h at 42
 
8
 
C using random hexamers and the Gene-
Amp RNA PCR kit (PerkinElmer). Each amplification mix contained
equal amounts of cDNA, 1.5 mM MgCl
 
2
 
, 30 pmol of each primer, 5% di-
methylsulfoxide, 200 mM of each dNTP (Boehringer), and 2 U of Taq DNA
polymerase (Amplitaq; PerkinElmer) in 1
 
3
 
 PCR buffer (PerkinElmer).
Control reactions were performed in the absence of reverse transcriptase.
The sequences and amplification parameters of the desLacZ, dystrophin,
and 
 
b
 
-actin have been described previously (Russo et al., 1998; Torrente
et al., 2000). PCR products were separated by electrophoresis on a 1%
agarose, 2.5% NuSieve gel, stained with ethidium bromide, and photo-
graphed under ultraviolet light. The 257-bp dystrophin PCR products
were cleaned in a Microspin S-400 column (Amersham Pharmacia Bio-
Figure 1. Characterization of
muscle-derived cells from
TnILacZ and Des-LacZ
transgenic mice. The des-
min immunofluorescence is
shown in B, D, F, and H, and
the corresponding phase–
contrast field is shown in A,
C, E, and G. The adherent
cells of the earlier preplates
display a low desmin immu-
noreactivity ranging from 5
to 15% (A and B), whereas
the sequential preplates were
enriched in their content of
desmin-positive cells: pp3 5
37% (C and D); pp5 5 85%
(E and F). Muscle-derived
cells isolated at pp6 con-
tained only 10% desmin-pos-
itive cells (G and H). Bar,
120  mm. 
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tech), digested with MaeIII at 55
 
8
 
C for 
 
.
 
5 h, and separated on a 17.5%
nondenaturing polyacrylamide gel.
 
Histochemistry and Immunocytochemistry on
Muscle Tissue
 
For histochemistry on tissue sections, samples were frozen in liquid nitro-
gen, cooled in isopentane, and cryostat-sectioned. Serial sections of differ-
ent thickness were examined (12 
 
m
 
m for histochemical detection of 
 
b
 
-gal
activity, 8 
 
m
 
m for immunohistochemical analysis, and 8 
 
m
 
m for hematoxy-
lin and eosin). Tissue sections were transferred to gelatin-coated glass
slides and fixed by dipping the slides in a cold solution of 0.25% glutaral-
dehyde in PBS, pH 7.4, for 15 min, rinsed twice for 5 min in PBS, and
stained overnight at 32
 
8
 
C with 1 mg/ml X-gal solution. Slides were exam-
ined by light microscopy for 
 
b
 
-gal–positive myofibers (Li et al., 1993). Im-
munohistochemical detection of dystrophin was performed with a poly-
clonal antibody against the COOH 60-kD Dys fragment as described
previously (Prelle et al., 1992). A polyclonal antibody anti-PECAM was
obtained from Santa Cruz Biotechnology, Inc. and used at a dilution of
1:100. Monoclonal anti–mouse vimentin was obtained from Sigma-Aldrich
and used at a dilution of 1:200 as described previously (Vicart et al., 1994).
A polyclonal antiserum against SV40 large T protein was obtained from
BD PharMingen and used at a dilution of 1:200 (Vicart et al., 1994). LacZ
and dystrophin positive myofibers were counted from adjacent hematoxy-
lin and eosin–stained sections, and expressed as a percentage of the total
cryosectioned fibers. Thus, 
 
b
 
-gal and dystrophin percentage reliably re-
flected the b-gal activity and dystrophin expression of the segment of mus-
cle from which the sections were taken.
Results
Expression of Muscle Markers in Cells Obtained after 
Various Numbers of Preplatings
Different populations of muscle-derived cells isolated
from hindlimb muscles by different numbers of preplat-
ings were observed. The adherent cells of the earlier pre-
plates display a low desmin immunoreactivity ranging
from 5 to 15%, whereas the sequential preplates were en-
riched in their content of desmin-positive cells (pp3 5
37%; pp4 5 78%; pp5 5 85%) (Fig. 1). These data sug-
gested that the attached cells of pp0–2 are mostly fibro-
blasts, as confirmed by their typical morphology and the
many desmin-positive cells remaining as floating cells in
the first 48 h of preplating. Surprisingly, the muscle-
derived cells isolated at pp6 contained only 10% desmin-
positive cells (Fig. 1, G and H). Since these cells were
mostly desmin negative, we believe that our pp6 are dif-
ferent than the muscle-derived cells described by Qu et al.
(1998). The morphology of these pp6 cells was predomi-
nantly similar to medium-sized blast cells. Endothelial-
like elongated cells were also present at this preplate. A
number of the pp6 cells (10%) detached from the plastic
surface and appeared similar to small lymphocytes. Few
M-cadherin–positive cells were found, especially in pp5.
These cell populations (pp0–pp6) consequently had a
variable ability to differentiate into myotubes when culti-
vated into a fusion medium for 14 d. Differentiated myo-
blasts were detected by immunostaining with antibody re-
active with MHCs. The number of myotubes obtained in
earlier preplates was much lower than in pp4 and pp5. In
contrast, the population of pp6 displayed a poor ability to
differentiate into myotubes (data not shown). The fusion
index of differentiated preplate cultures showed an in-
creased kinetics of differentiation as follows: pp0 5 10%,
pp1 5 15%, pp2 5 17%, pp3 5 30%, pp4 5 50%, pp5 5
75%, and pp6 5 12% (graphical in Fig. 2). Few myotubes
were also found in grown conditions (pp3 = 7% and pp4–
pp5 = 8%). These data were confirmed by immunoblot-
ting experiments after maintaining the cells in a fusion
medium for 14 d (Fig. 2). Dystrophin and slow MHCs
were threefold higher in pp4 and pp5 than in the other
preplates (Fig. 2).
Figure 2. Immunoblotting analysis of dystrophin and slow MHCs of different populations of muscle-derived cells when cultivated in fu-
sion medium. The first lane of all immunoblotting corresponds to a homogenate of normal muscle as control (CTR). The populations
(pp0–pp6) had a variable ability to differentiate into myotubes when cultivated in a fusion medium for 14 d, resulting in an increase in
dystrophin and MHC synthesis in pp3–pp5 (A). In contrast, a significant reduction in the amount of this myogenic marker expression
was observed in pp6. Utrophin (Utr) immunoblotting (B) indicated a presence in all preplatings including pp6. These data were also
confirmed by sMHC immunostaining (A, top, corresponding to pp3–pp5). The enumeration of differentiated myoblasts containing two
or more nuclei (i.e., fusion index) is shown graphically beside Western blotting condition. The error bars represent the SEM from three
independently derived preplating cultures.The Journal of Cell Biology, Volume 152, 2001 340
Specific Sca-1, CD34 Expression in
Muscle-derived Cells
Flow cytometric analysis of muscle-derived cell preplates
from hindlimb muscles was performed. As shown in Fig. 3,
a distinct population of Sca-11 cells was found in all seven
preplates, but CD341 cells were observed only in pp6 (Fig.
3, A and C). The morphological distribution of muscle-
derived cells after flow cytometry showed different subpop-
ulations within the Sca-11 cell population. The profile of
these cells varied from cells with large diameters (pp0–4) to
cells with small diameters (pp5–6). Double staining of mus-
cle-derived cells with Sca-1 and CD34 (Fig. 3, B and C)
showed that 69% of cells at pp6 coexpressed both markers.
However, all Sca-11 cells were not CD341 and a fraction of
the population of pp6 was only positive for CD34 (7%).
The Sca-1, CD34 double-positive muscle-derived cell popu-
lation was gated in a region of small cell diameter, a pheno-
type characteristic of hematopoietic progenitors. Since it
had been demonstrated previously that Sca-1 is expressed
on a high percentage of activated T lymphoid cells, a double
staining with antibodies against Sca-1 and the lymphoid
CD4 and CD8 markers was performed. As expected, no
lymphoid markers were detected in any preplates (Fig. 3 B).
Clonogenic Ability of Sca-1, CD34 Double-positive 
Cells and Self-Renewal
To verify whether the Sca-1 and CD34 double-positive
cells (i.e., pp6 cells) or muscle-derived cells contained he-
matopoietic progenitor cells, a colony-forming unit in cul-
ture assay in methylcellulose was performed (Delassus
Figure 3. Immunophenotyping of the muscle-derived cells using FACScan™ analysis. Muscle-derived cells were tested for CD34 and
Sca-1 single (A) and double (B) expression. A distinct population of Sca-11 cells was found in all seven preplates, but CD341 cells were
observed only in pp6 (A). The morphology distribution of muscle-derived cells after flow cytometry showed different subpopulations
within the Sca-11 cell population (B). The profile of these cells varied from cells with large diameters (pp0–4) to small diameters (pp5–6).
The majority of cells derived from pp3 (B, top left quadrant) and pp5 (B, top right quadrant) highly express Sca-1, but were also
poorly CD341. Muscle-derived cells from pp6 showed 69% double-positive cells for CD34 and Sca-1 markers (B, bottom left quadrant).
However, all Sca-11 cells were not CD341 and a fraction of the population of pp6 was single-positive for CD34 (7%). The Sca-1, CD34
double-positive muscle-derived cell population was gated in a region of small cell diameter, a phenotype characteristic of hematopoietic
progenitors. Labeling of cells with antibodies against Sca-1 and the lymphoid CD4 and CD8 markers was also performed (B, bottom
right quadrant). Dead cells were excluded from analysis. Calculation of Sca-1 and CD34 single (C, left) and double (C, right) positive
cells as the percentage of cells contained within all preplates is shown graphically.Torrente et al. Intraarterial Injection 341
and Cumano, 1996). Cells were cultured under conditions
that promote myeloid cell development (i.e., presence of
IL-3 and SCF). The cloning efficiency was 22% (z1 cell in
5; Fig. 4) and two types of clones derived from Sca-1,
CD34 positive cells were identified: (1) clones with a re-
stricted myeloid potential that were able to differentiate
into either macrophages or mast cells; (2) multipotent
clones that displayed a multimyeloid potentiality (mainly
Figure 4. In vitro differentia-
tion potential of muscle-
derived cells under myeloid
conditions. Photomicro-
graphs A and B show the pp6
forming clones in methylcel-
lulose under myeloid condi-
tions. Verification of the
multimyeloid nature of the
resulting cells was performed
by May-Grunwald-Giemsa
staining. Two types of clones
derived from Sca-1, CD34
positive cells (pp6) were
identified: (1) multipotent
clones that displayed a multi-
myeloid potentiality (mainly
macrophages, megakaryo-
cytes, and granular polymor-
phonuclear cells) (C, D, and
E); and (2) clones with a re-
stricted myeloid potential
that were able to differenti-
ate into either macrophages
or mast cells (F). Bars: (A
and B) 120 mm; (C and D) 50
mm; (E and F) 120 mm.
Figure 5. To determine whether individual muscle-derived cells (i.e., pp6) exhibit stem cell characteristics of self-renewal and pluripo-
tentiality, individual clones were analyzed. To establish clones, pp6 were plated at z10 cells/cm2. Single cells replicated as typical mus-
cle-derived stem cells (A) and differentiated after 15 (B), 30 (C), and 45 (D) d of culture. Undifferentiated, rounded (indicated by
arrows) muscle-derived stem cells were evident in each clonal line. Therefore, clones derived from single cells give rise to both muscle-
derived stem cells and differentiated cells, indicating stem cell characteristics. Bar, 120 mm.The Journal of Cell Biology, Volume 152, 2001 342
macrophages, megakaryocytes, and granular polymorpho-
nuclear cells). Verification of the multimyeloid nature of
the resulting cells was performed by May-Grunwald-
Giemsa staining (Fig. 4). In some experiments, cultures of
pp0–5 in methylcellulose supplemented with IL-3 and SCF
showed no colonies, even after 28 d of culture. These data
suggest that there is a strong relationship between the ex-
pression of CD34 and the in vitro myeloid differentiation.
To determine whether muscle-derived cells exhibit stem
cell characteristics of self-renewal, pp6 were plated at z10
cells/cm2, isolated with cloning cylinders, and transferred
to separate wells and finally to individual flasks. Single
cells replicated as typical muscle-derived stem cells and
underwent morphologic differentiation (Fig. 5). Using im-
munohistochemistry, these cells were found to be positive
for the expression of several markers, such as PECAM
(endothelial and hemopoietic cells), desmin (myoblasts
and smooth muscle cells), and Mac-1 (macrophages). Un-
differentiated muscle-derived stem cells were evident in
each clonal line. Therefore, clones derived from single
cells give rise to both muscle-derived stem cells and differ-
entiated cells, indicating stem cell characteristics.
Adhesion of Sca-1, CD34 Positive Cells in
Muscle Microcirculation
Since intravenous injection of precursor cells offers the ad-
vantages of a total body distribution, we believe that this
approach is also limited by physiological dispersion of in-
jected cells in the blood-stream of several tissues (espe-
cially in liver and lungs). In our experiments, we verified
the possibility in an elective biodistribution in muscle
limbs after intraarterial injection of muscle-derived stem
cells. We tested the adhesive behavior of Sca-1, CD34 pos-
itive cells to muscle vessels. Boluses of 7 3 105 fluores-
cently labeled cells were injected through a carotid artery
catheter and their adhesion to the pectoral muscle vessels
was recorded (Fig. 6). Sca-1, CD34 cells had a small diam-
eter and interacted especially with muscle capillaries, but
rarely with venules. The Sca-1, CD34 positive cells (in
pp6) were distinguishable from the other preplates by
their significant adhesive properties to the capillaries (data
not shown). Adhesion fractions of injected pp6 were de-
termined by counting the number of interacting cells in
each muscle vessel per number of cells that passed through
the same vessel during an injection. Injected cells adhered
prevalently within muscle capillaries and the adhesion
fraction was z89%.
Distribution of Donor Des-LacZ Positive Sca-1, CD34 
Cells after Intraarterial Injection in mdx Mice
Cells obtained from pp6 of newborn Des-LacZ mice were
intraarterially injected into five C57BL/10ScSn mdx/mdx
mice. PCR analysis for the LacZ gene and for the normal
dystrophin genes in various tissues from these mice indi-
Figure 6. Intravital micros-
copy: muscle-derived cells
(pp6) firmly adhere in mus-
cle capillaires. To improve
contrast between the intra-
and extravascular compart-
ment, the animals were in-
jected intravenously with a
low dose of FITC-dextran.
Venules (A) and arterioles
(E) are indicated by aster-
isks and arrowheads, respec-
tively. The BCECF-labeled
cells (bright dots indicated
by arrows) can be seen in
the muscle capillaries (A, B,
and C) 1 min after intraarte-
rial injection. Arrows in D
indicate a migrated BCECF-
labeled cell in the perivascu-
lar space of a muscle venule
1 h after injection. Images
before (E) and during the
injection (F) are also pre-
sented.Torrente et al. Intraarterial Injection 343
cated that donor cell distribution remains close to the in-
jected hindlimb (Table I). Donor cells were found in the
hindlimb soleus and gastrocnemius muscles of all mice
injected; two of these mice also had donor cells in the
TA and quadriceps muscles. Lungs, liver, brain, kidneys,
bones with bone marrow, triceps brachii, diaphragm, and
controlateral untreated hindlimb muscles were negative
(Table I). Tissues from untreated mice scored negative.
Detection of LacZ and Dystrophin Transcripts in mdx 
Mice Injected Intraarterially with Sca-1, CD34 Cells
To assess the in vivo ability of pp6 cells to differentiate
through the myogenic lineage, RT-PCR for dystrophin and
LacZ mRNAs analysis was performed on mdx mice which
were injected intraarterially with Sca-1, CD34 positive cells
obtained from the Des-LacZ donor. Tissues which were
shown by standard PCR to contain donor cells were evalu-
ated for desmin-LacZ and dystrophin transcripts. Total
RNA extracted from untreated and treated mdx mice was
used as a template for RT-PCR. Digestion of the dystro-
phin RT-PCR reaction products by MaeIII allowed us
to distinguish between normal and mutated dystrophin
mRNAs. The normal dystrophin gene gave a 207-bp band
plus two 25-bp fragments, whereas the mutated dystrophin
gave a 207-bp band plus a single 50-bp fragment. Normal
dystrophin and LacZ mRNAs were found in the soleus,
TA, gastrocnemius, and quadriceps muscles of treated mice
(Table I and Fig. 7), suggesting that transplanted Sca-1,
CD34 positive cells participated in myogenesis. Neither
LacZ or dystrophin transcriptional activity was detected in
the controlateral hindlimb muscles (Table I).
Colocalization of Dystrophin and LacZ Expression
To identify the ability of intraarterially injected tissues to
transcribe normal dystrophin and LacZ mRNAs, his-
tochemical staining on cryostat sections of muscles, brain,
liver, lungs, kidneys, and bones were performed. b-Gal–
positive nuclei were detected only in striated muscles of
the injected hindlimb. Positive LacZ myofibers were
found in restricted areas. Muscle fibers scoring positive
had peripheral nuclei and fiber diameters varied from 20
to 60 mm. 10 different fibers having b-gal–positive nuclei
were counted in the soleus, corresponding to z1% of total
fibers per cross sectional area, and 15 positive fibers, cor-
responding to 0.5% of total fibers in a given cross section,
were counted in the quadriceps. The pattern of LacZ gene
expression was compared with that of dystrophin, and typ-
ical immunofluorescence for dystrophin was found in the
same fibers that contained b-gal–positive nuclei (Fig. 8).
The dystrophin antibody did not cross-react with autoso-
mal dystrophin-related proteins such as utrophin. Positive
fiber always seemed to exist as isolated small groups (one
to five positive fibers), suggesting that there might have
been clonal proliferation of some donor cells, which con-
tributed to the formation of the fibers in that region of the
muscle. Control mdx muscles contained rare revertant fi-
bers that were positive for dystrophin (Hoffman et al.,
1990), but also b-gal negative.
b-Gal Histochemistry in TA of CD1 Mice Injected 
Intraarterially and Damaged 48 h Later
21 d after intraarterial injection of Sca-1, CD34 positive
muscle-derived cells derived from the pp6 of TnILacZ,
clusters of b-gal–positive myofibers (12% 6 0.8 per cross
section) of 20–60-mm diameter were observed (Fig. 9, B–D).
These fibers had peripherally located nuclei and were
along the needle tracks made in the TA 2 d after the in-
traarterial injection of the pp6 cells. Fibers of the same
section exhibited different levels of LacZ activity, some fi-
bers being more intensely stained than others. Most of the
labeling was restricted to regions near the three needle
tracks done in the muscles where most of the muscle re-
generation was present. TA controlateral muscle did not
show any positive cells. In a second similar experiment,
the damage to the muscle fibers 48 h after the intraarterial
injection of the same type of cells was achieved by a pro-
Table I. b-Gal and Dystrophin Detection by PCR Localization 
in Tissues of Mice Injected Intraarterially with Muscle-derived 
CD341Sca-11 Cells
Tissues analyzed 30 d after 
intraarterial injection
n positive mice/
total treated mice
Soleus muscle 5/5
Quadriceps femoralis muscle 2/5
TA muscle 2/5
Triceps femori muscle 1/5
Gastrocnemius muscle 5/5
Controlateral limb muscles 0/5
Brain 0/5
Liver 0/5
Heart 0/5
Kidney 0/5
Lung 0/5
Bone and bone marrow 0/5
Diaphragm 0/5
Triceps brachii 0/5
Figure 7. Detection by PCR of donor cells in the tissues of mdx
mice. (A) Muscle-derived cells from Des-LacZ transgenic mice
were injected intraarterially into mdx/mdx mice and the animals
were examined 21 d later. Genomic DNA was extracted and ana-
lyzed by PCR for the des-LacZ transgene and the normal (25 bp)
and mdx (50 bp) dystrophin gene. (B) Actin, the normal (25 bp)
and mdx (50 bp) dystrophin, and des-LacZ expression was de-
tected by RT-PCR. The 450-bp band of the des-LacZ transgene,
indicating injected cells in mdx mice, was found in the analyzed
muscle tissues. LacZ expression, indicated by the 272-bp band in
RT-PCR, was also found in the same tissues showing the myo-
genic program. Actin expression was detected in all tissues. Nor-
mal dystrophin expression was indicated by the 25-bp band for
wild-type dystrophin. Lane 1, treated muscle tissues; lane 2, con-
trol des-LacZ; lane 3, control mdx/mdx.The Journal of Cell Biology, Volume 152, 2001 344
longed (60-min) swimming exercise. A preliminary experi-
ment has demonstrated that this type of activity damaged
25% of the muscle fibers in the TA muscle, as indicated by
the detection of intracellular calcium with alizarin red
staining (data not shown). The histology of muscles of
these mice presented foci of degenerating and regenerat-
ing fibers 24 h after the swimming exercise. In fact, a sig-
nificant number of basophilic myotubes with vesicular
myonuclei and numerous myotubes of small diameters
with central nuclei were evident (data not shown). An in-
flammatory cellular infiltrate was also present. The cell in-
filtration decreased rapidly and disappeared starting 3 d
after exercise. As in the first experiment, the animals were
killed 21 d after the intraarterial injection. Quite surpris-
ingly, this type of exercise-induced damage did not in-
crease the percentage of b-gal–positive muscle fibers, as
only 1% of them were positive.
LacZ Expression in Muscle Injected with
Muscle-derived and Endothelial Cells
In an attempt to investigate whether the Sca-1, CD34 posi-
tive cells have characteristics of bilineag-committed pre-
cursors (hemopoietic and endothelial), the intramuscular
injection of pp6 was compared with the injection of an en-
dothelial cell line. The ability of injected pp6, labeled with
a LacZ transgene, to fuse with host muscle fibers was in-
vestigated 30 d after intramuscular transplantation. A
small number of b-gal myofibers surrounding the injected
area were observed in these muscles (z3% per cross sec-
tion; Fig. 9 A). The endothelial cell line was isolated as de-
scribed in Materials and Methods. These cells expressed
the vimentin and the b-gal placed under a vimentin pro-
moter. It has been shown that myoblasts and regenerating
myofibers express the vimentin protein (Tokuyasu et al.,
1984; Sarnat, 1992). The fibers which had been colonized
by the endothelial cells expressed the LacZ. They also
contained the large T antigen with a thermosensitive mu-
tation to achieve inactivation of large T antigen by tem-
perature shift when necessary. Thus, these cells were able
to differentiate when injected in the TA muscles of ani-
mals having a body temperature of 378C. 30 d after trans-
plantation, intensely b-gal– and vimentin-positive mono-
nuclear cells were observed in different areas of the cross
section of the injected TA muscle (Fig. 10). The positive
Figure 8. Sections of the
muscles of mdx/mdx mice in-
jected intraarterially with
muscle-derived pp6 cells
showing dystrophin and des-
LacZ gene expression. LacZ
staining of muscle sections
from donor des-LacZ mice
was performed as a positive
control (A and B). Some
LacZ-positive myofibers (C
and E) were found in the in-
traarterially injected mdx
muscles that colocalized with
dystrophin-positive myofi-
bers of the adjacent sections
(D and F). Bars, 50 mm.Torrente et al. Intraarterial Injection 345
cells were spread throughout the muscle, but fused poorly
with the host’s fibers. The PECAM staining confirmed
that injected cells were still endothelial cells (data not
shown). Interestingly, endothelial injected cells remained
as mononuclear cells close to the muscle fibers. Very few
cells expressed the large T antigen in their nuclei. Few of
the perithelial layer of muscle vessels in the injected area
were positive to LacZ and vimentin staining, indicating an
incorporation of the endothelial injected cells in these
sides (Fig. 10, B, D, and F).
Discussion
We have further investigated a new strategy to restore
dystrophin expression in mdx mouse muscles by an in-
traarterial injection of normal purified Sca-1, CD34 mus-
cle-derived stem cells. Marker transgenic DNA was found
in muscles of mdx/mdx mice demonstrating the migration
of these cells from the blood vessels. These muscle-
derived cells crossed the vessel barriers thus leading to a
mosaic expression of the marker gene in muscles of the in-
jected hindlimb of adult mice. The precise pathway used
by the transplanted cells to home to host muscle tissues is
not known. However, the adhesion-initiating vascular dia-
pedesis of these cells is high in capillaries. Based on our
findings, the cells might have actively migrated in re-
sponse to chemoattractants, as described previously, after
bone marrow transplantation (Mazo et al., 1998; Deog-
Yeon et al., 2000).
The fate of injected Sca-1, CD34 positive cells was eval-
uated by examining tissues of five mdx/mdx mice. We
found transcription and expression of LacZ and normal
dystrophin genes in muscles of the injected hindlimbs. Un-
expectedly, PCR and RT-PCR analysis revealed the ab-
sence of injected cells in other muscles and tissues of the
treated mice. Histochemical analysis of muscles showed
Figure 9. Intramuscular
transplantation of muscle-
derived stem cells. (A) A
small number of b-gal myo-
fibers surrounding the in-
jected area were observed in
muscles injected with pp6, la-
beled with a LacZ transgene,
and investigated 30 d after
intramuscular transplantation.
We also verified whether
Sca-1, CD341 stem cells re-
main in the muscle after in-
traarterial injection without
differentiation and partici-
pate actively to muscle for-
mation only after muscle
damage. Thus, muscle dam-
age with needle insertions
was induced 48 h after in-
traarterial injection of mus-
cle-derived pp6 cells in the
TA muscle of injected hind-
limb. The myogenic potenti-
alities of the injected cells
was determined by LacZ
staining. TA muscle dam-
aged with needle insertions
showed a higher increase of
LacZ expression (B, C, and
D) compared with intramus-
cular injections (A). In these
experiments, fibers of the
same section exhibited dif-
ferent levels of LacZ activity,
some fibers being more in-
tensely stained than others.
Most of the labeling was re-
stricted to regions near the
three needle tracks made in
the muscles where most of
the muscle regeneration was
present.The Journal of Cell Biology, Volume 152, 2001 346
colocalization of dystrophin and b-gal in muscle fibers. Pe-
ripherally nucleated double-positive fibers were generally
grouped in some segments of the muscles and always
seemed to exist in small groups, suggesting that there
might have been clonal proliferation of some donor cells,
later contributing to the formation of several muscle fi-
bers. Thus, muscle-derived cells injected into arterial cir-
culation of a congenital dystrophinopathy partly restored
normal dystrophin production in striated muscles.
In this study, we used a muscle culture system for facili-
tating the enrichment and purification of Sca-11 and
CD341 cells. We found a lower content of desmin-positive
cells in a population of purified muscle-derived cells that
display both CD34 and Sca-1 as markers of progenitors
cells. This population was obtained with a purification
method described in Qu et al. (1998), but with a different
medium and growth conditions. However, these cells
showed a poor ability of myogenic differentiation, indicat-
ing that they are distinct from the pp6 cells described in
Qu et al. (1998). These cells could represent a pool of stem
cells capable of commitment to more than one lineage (he-
mopoietic, endothelial, and muscular) given the right envi-
ronmental cues. However, the major problem encoun-
tered in this study was the poor ability of the pp6 cells to
undergo muscle differentiation when injected directly in
the muscle. It is conceivable that engraftment efficiency
may depend on the inflammatory consequences of muscle
directly injected compared with the arterial injection of
the hindlimb where histologic features of muscles are in-
varied. These data do not preclude the possibility of the
muscle-derived Sca-1, CD34 double-positive cells repre-
senting the immediate progenitors to satellite cells. The
descendants of the activated satellite cells, myogenic pre-
cursor cells, undergo multiple rounds of division before
fusing to existing or new fibers. Quiescent satellite cells ex-
press c-met and M-cadherin proteins, but do not express
markers of committed myoblasts such as Myf-5, MyoD,
and desmin (Cornelison and Wold, 1997; Sabourin et al.,
1999). The total number of satellite cells in muscle remains
relatively constant, suggesting that a capacity for self-
renewal in the satellite cell compartment maintains the
population of quiescent cells (Bischoff, 1994). However, the
mechanism by which satellite cells undergo self-renewal in
skeletal muscle is poorly understood. Muscle stem cells
may undergo asymmetric cell division to generate two
daughter cells: a committed myogenic precursor and a
pluripotent “self.” Moreover, it remains possible that mus-
cle-derived stem cells represent an independent stem cell
population separate from the satellite cells. Additionally,
circulating pluripotent cells derived from the bone marrow
might be the common putative stem cell population
present in many different tissues.
To analyze the potential role of the endothelial CD341
progenitor cells of our purified muscle-derived cells, we
Figure 10. Intramuscular in-
jection of an endothelial cell
line. These cells expressed vi-
mentin and the b-gal placed
under a vimentin promoter.
30 d after transplantation, in-
tensely b-gal (A and B) and
vimentin (E and F) positive
mononuclear cells were ob-
served in different areas of
the cross sections of the in-
jected TA muscle. Few in-
jected cells still remained
large T antigen positive (C
and D). Few perithelial lay-
ers of muscle vessels in the
injected area were positive to
LacZ and vimentin staining,
indicating an incorporation
of the endothelial injected
cells in these sides (arrow-
heads in B, D, and F). Bar,
50 mm.Torrente et al. Intraarterial Injection 347
performed in vivo studies focusing on the muscle injec-
tions of endothelial cells. Interestingly, endothelial cells
injected intramuscularly remained as mononuclear cells
under the basal lamina of the host muscle fiber in the same
location as muscle satellite cells and fused poorly with host
fibers. Few LacZ- and vimentin-positive cells were also lo-
cated at the perithelial sides of muscle vessels.
It is extremely interesting to note that the efficiency of
Sca-1, CD34 muscle engraftment increased significantly to
12% when TA muscle of the injected hindlimb was dam-
aged 48 h after intraarterial injection. This observation
suggests that these cells first attached to the capillaries as
Sca-1, CD34 positive stem cell remaining in the muscle
without differentiation and participate actively in muscle
formation only after muscle damage. Thus, the myogenic
potentialities of the injected cells are determined by the
location of the precursors at the beginning of muscle and
blood vessel damage. In another experiment, the damage
to the leg muscles of mdx mice 48 h after the intraarterial
injection of TnILacZ Sca-11CD341 cells (pp6) was done
by a swimming exercise which was shown to damage the
muscle fibers of mdx mice. 1 mo later, we observed only
1% of b-gal–positive fibers in the leg injected arterially.
There are two possible hypotheses to interpret the results
of these two experiments with muscle damage produced
with a needle and with exercise. The first is that the Sca-
11CD341 cells are attached to the capillaries and partici-
pate in muscle regeneration when not only the muscle fi-
bers, but also the blood vessels, are damaged. The second
hypothesis is that the Sca-11CD341 cells are still present
in the blood circulation and are attracted to the damaged
muscle when the blood vessels are damaged. The first hy-
pothesis means that there are two types of muscle regener-
ation. The first type (low regeneration), which would oc-
cur after damage only to the muscle fibers, would involve
the participation of only the satellite cells attached to the
muscle fibers. The second type of muscle regeneration (in-
tense regeneration) would occur after a damage to the
muscle involving not only the muscle fibers, but also the
blood vessels. With this more intensive damage, the regen-
eration would involve not only the participation of satel-
lite cells, but also of stem cells already attached to the
blood vessels or present in the blood circulation. The low
regeneration would occur after intense muscle activity.
The intense regeneration would occur after a major injury
to the muscle (an accident, a bite, or a crush). The pres-
ence of precursor cells attached to the blood vessels and
participating in muscle regeneration only after damage to
these vessels would explain why Grounds and McGeachie
(1992) observed that within a few hours after a muscle
crush there were more myogenic cells than satellite cells.
This intense regeneration hypothesis also explains why
there is muscle regeneration after muscle irradiation when
notexin is injected intramuscularly (Heslop et al., 2000),
since these injections also damaged the blood vessels.
More importantly, this hypothesis would account for the
absence of muscle regeneration in DMD patients despite
the presence of stem cells originating from the bone mar-
row or other sources already attached to the blood vessels
and capable of forming myogenic cells.
During embryonic vasculogenesis, primordial perithelial
cells, which later would generate smooth muscle and con-
nective tissue of the vessel wall, develop in the outermost
portion of vasculogenic clusters (DeRuiter et al., 1997). It
is possible that these multipotent mesodermal progenitors
remain associated to the tissue vasculature as perivascular
cells and acquire a commitment depending on the tissue
(Bianco and Cossu, 1999). In this model, the mesodermal
progenitors would represent the source of cells to develop
and regenerate tissue. Thus, when muscle stem cells are in-
jected by intraarterial circulation, they would become as-
sociated with the vasculature and would be able to differ-
entiate into the myogenic lineage after muscle and blood
vessel damage. In contrast, the direct muscle injection of
these cells did not give the correct lineage relationship be-
tween endothelial and perithelial progenitor cells.
This raised the possibility that the precursor Sca-1,
CD34 muscle-derived cells with characteristics of bilin-
eage-committed precursors (hemopoietic and muscular)
may prevent irreversible pathological damage and allow
engraftment in many distant areas affected by the disease.
It would also be important to know the muscle-derived
signals governing cell migration. Thus, further accurate
studies of the Sca-1, CD34 muscle-derived cells will be es-
sential to improve transplantation efficiency.
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